Bernard Poncioni
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, Chemical Synthesis and Analysis, Click Chemistry and Applications
Most-Cited Works
- → New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development(1998)199 cited
- → Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability(1996)78 cited
- → CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity(1993)36 cited
- → Lack of effect of desferrioxamine on in-vitro HIV-1 replication(1991)15 cited
- → Synthesis of Potent and Orally Active HIV‐Protease Inhibitors(1996)9 cited
- → Synthesis and Pharmacological Evaluation of CGP 57813 and CGP 61755, HIV-1 Protease Inhibitors from the Phe-c-Phe Peptidomimetic Class(1996)5 cited
- → Anti-HIV-1 Activity in Vitro of Ceftazidime Degradation Products(2001)4 cited
- → ChemInform Abstract: Aza‐Peptide Analogues as Potent Human Immunodeficiency Virus Type‐1 Protease Inhibitors with Oral Bioavailability.(1996)3 cited
- → Inhibition of HIV protease activity by various dipeptide isosteres(1991)2 cited
- [1957 Influenza pandemic & other viral respiratory diseases in Geneva, Switzerland].(1959)